Skip to main content
. 2021 Jun 28;17(10):3747–3756. doi: 10.1080/21645515.2021.1932217

Supplementary Table S1:

Demographic characteristics (total vaccinated cohort) and 10-year varicella person-year rate (per-protocol efficacy cohort) of study participants per country in the Active Control group

Characteristic
Czech Republic
Greece
Italy
Lithuania
Norway
Poland
Romania
Russia
Slovakia
Sweden
Age in months, mean ± SD 15.3 ± 3.1 15.1 ± 2.8 13.9 ± 2.1 14.4 ± 2.2 14.1 ± 1.0 12.9 ± 1.2 15.3 ± 2.9 12.6 ± 1.2 15.4 ± 2.4 15.5 ± 2.0
Gender, % female 48.1 48.8 57.5 46.2 55.2 53.3 42.6 48.3 46.4 37.2
Ethnicity, n (%)European
Arabic or North African
Other
 
184 (99.5)

41 (95.3)

38 (95.0)

93 (100.0)

27 (93.1)

135 (100.0)

46 (97.9)

143 (100.0)

68 (98.6)

43 (100.0)
  0 (0.0) 2 (4.7) 1 (2.5) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
  1 (0.5) 0 (0.0) 1 (2.5) 0 (0.0) 2 (6.9) 0 (0.0) 1 (2.1) 0 (0.0) 1 (1.4) 0 (0.0)
Care type, n (%)At least one sibling at homeAttending a day care centerAttending a childminderAt least once a week contact   53 (28.6)

12 (27.9)


7 (17.5)


10 (10.8)


10 (34.5)


35 (25.9)


6 (12.8)


32 (22.4)


31 (44.9)


13 (30.2)
  3 (1.6) 1 (2.3) 9 (22.5) 26 (28.0) 13 (44.8) 7 (5.2) 0 (0.0) 125 (87.4) 1 (1.4) 24 (55.8)
  13 (7.0) 9 (20.9) 7 (17.5) 1 (1.1) 8 (27.6) 4 (3.0) 0 (0.0) 12 (8.4) 4 (5.8) 4 (9.3)
  176 (95.1) 40 (93.0) 35 (87.5) 78 (83.9) 19 (65.5) 127 (94.1) 47 (100.0) 131 (91.6) 67 (97.1) 32 (74.4)
10-year person-year rate of varicella, n/T (95% CI)* 0.20 (0.17─0.23) 0.00 (undefined) 0.08 (0.04─0.15) 0.05 (0.03─0.07) 0.16 (0.10─0.26) 0.06 (0.04─0.08) 0.00 (undefined) 0.07 (0.05─0.10) 0.15 (0.11─0.19) 0.21 (0.15─0.30)

SD, standard deviation; n (%), number (percentage) of participants in a given category; n/T (95% CI), person-year rate (95% confidence interval). *data for Czech Republic, Lithuania, Poland, Romania and Slovakia have been published31